Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytotoxic T Cell Therapy for Post Transplant Lymphoproliferative Disease: Randomized Controlled Trial in Transplant Recipients

NCT00033475 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT00033475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00033475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytotoxic T Cell Therapy for Post Transplant Lymphoproliferative Disease: Randomized Controlled Trial in Transplant Recipients
Lead sponsor
University of Edinburgh
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2001
Completion date
Not reported
Enrollment
50 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoproliferative disorder